BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 7, 2008
View Archived Issues
MDV-3100 well tolerated, reduces PSA in castration-resistant prostate cancer patients
Read More
In vitro and in vivo activity against hepatocellular cancer seen with CUDC-101
Read More
PDL BioPharma reports development of anti-TweakR antibody with antitumor activity
Read More
Serenex describes discovery of SNX-5422, an Hsp90 inhibitor in phase I development
Read More
F-14512 activity depends on polyamine transport system status of tumors
Read More
Positive preclinical data of Palomid-529 in models of ocular disorders
Read More
Evotec completes acquisition of Renovis
Read More
Corcept reports promising results from human microdosing study of CORT-108297
Read More
Epix initiates phase IIb clinical trial of PRX-03140 in combination with Aricept
Read More
NanoViricides reports initial results from mouse studies of HivCide-I for HIV/AIDS
Read More
Antennapedia Trojan peptide-p21 fusion protein inhibits tumor cell growth
Read More
Bayer Schering Pharma to market new low-dose oral contraceptive in Europe
Read More
TG-100801's clinical evaluation discontinued due to phase IIa results
Read More
Catalyst selects second-generation factor VIIa variant as candidate for hemophilia
Read More
DiaMedica enrolls final patient in phase DM-83 clinical trial
Read More
FDA accepts for review Cinryze complete response submission
Read More
QRxPharma releases successful phase III study results for Q-8003-IR
Read More
Cadence completes full enrollment in phase III CLIRS clincial trial of Omigard
Read More
FDA Advisory Committee recommends against approval of Fentora expanded label
Read More
Genentech initiates phase II clinical trial of GDC-0449 in metastatic colorectal cancer
Read More
Novel agents for treating autoimmune diseases disclosed in recent Pharmacopeia patents
Read More
Targacept designates neuronal nicotinic receptor drug in smoking cessation program
Read More
Recent patents claim novel therapeutic agents for psychosis, depression and anxiety
Read More
LLS and MannKind enter agreement to develop targeted tyrosine kinase inhibitor
Read More
Glenmark launches topical antifungal cream Onabet in India
Read More